PLOS ONE has retracted two 2014 papers from a group of researchers, after an institutional investigation confirmed image duplication. Although the authors initially asked to correct the figures in the two papers, they ultimately agreed with the decision to retract.
Mrinal K. Maiti—an associate professor at the Indian Institute of Technology at Kharagpur and corresponding author on the two now-retracted PLOS ONE papers—also corrected a 2016 paper published in PLOS ONE over figure-related errors. Maiti is the only author in common to all papers.
A physics journal says it has planned for several months to retract a 2006 paper by a prominent researcher with multiple retractions, after a concerned reader notified the editor about extensive duplication.
But, more than seven months after receiving the complaint, the journal Thin Solid Films has not yet taken action.
So what’s taking so long?
According to the editor, Joseph Greene, the delay occurred because “the publication team missed the request.”
Duplication allegations have followed the paper’s corresponding author Naba K. Sahoo for the past few years. Sahoo, a top physicist in India, has already had seven papers retracted for duplication—five earlier this year (1, 2), and two last year.
A journal retracted a paper about how conflicts of interest might be influencing research into the link between vaccines and autism because — wait for it — the authors failed to disclose conflicts of interest.
According to the retraction notice, the editors retracted the paper without the authors’ agreement, because the authors had a host of personal and professional interests in the field they didn’t declare, such as being associated with organizations involved in autism and vaccine safety. What’s more, the article also contained “a number of errors, and mistakes of various types that raise concerns about the validity of the conclusion.”
What Caught Our Attention: Everyone makes mistakes — but some are more amusing than others. In one recent correction, the publisher (Wiley) admitted to including a proofreader’s query in the published manuscript. But didn’t say what the query was.
Last month, a colleague of emergency medicine doctor Daniel Waxman sent him some newly reported findings that took him by surprise. Waxman knew from the title of a press release about the recent paper — “Nearly Half of U.S. Medical Care Comes From Emergency Rooms” — that something was wrong.
Immediately I said, that’s not true. It’s just crazy.
Waxman quickly realized the mistake: The data were based only on care provided in hospitals — much of which, not surprisingly, originates from emergency departments (EDs). But the title of the paper, the abstract, and other places in the text do not specify that. What’s more, the press release about the study says the findings relate to “all medical care.” The journal has since changed the paper, including the title, to make that distinction clear, but not provided any editorial notice indicating the text had been updated. Meanwhile, the press release and news stories about the original study continue to report the “surprising” original findings.
A $10 million defamation suit filed by a Stanford University professor against a critic and a journal may be an assault on free speech, according to one lawyer, but at least it’s “well written.”
Kenneth White, a lawyer at Southern California firm Brown White & Osborn who frequently blogs about legal issues related to free speech at Popehat, told us:
It’s not incompetently drafted, but it’s clearly vexatious and intended to silence dissent about an alleged scientist’s peer-reviewed article.
Scientists have publicly bemoaned the suit’s existence, as reported by several outlets, including Mashable and Nature.Mark Jacobson, an engineering professor at Stanford, has alleged that he was defamed in a June article published in the Proceedings of the National Academy of Sciences (PNAS), which was critical of a 2015 paper co-authored by Jacobson in the same journal. In a complaint filed Sept. 29 in the Superior Court of the District of Columbia, Jacobson accused the journal’s publisher, the National Academy of Sciences, and the paper’s first author, Christopher Clack, an executive at a renewable energy analysis firm, of libel.
White told us that there are several pitfalls that could trip up the lawsuit, including a DC law that allows defendants an early opportunity to ask the court to dismiss cases muzzling free speech and recover attorneys’ fees. But another attorney said the complaint should at least clear the lowest hurdle in the way of getting to trial.Continue reading Lawyers call libel suit against journal and critic “lawless” but “well written”
What Caught Our Attention: A big peer review (and perhaps academic mentorship) fail. These researchers used the wrong anticoagulant for their blood samples, leading them to believe that certain blood components were fighting microbes. The authors counted the number of colonies to show how well or poorly Tuberculin mycobacteria were growing in cultures — but blood samples need anticoagulants to prevent clots before analysis, and they used an anticoagulant that actually prevented the microbes from colonizing. The authors (and reviewers) should have known this from Continue reading Caught Our Notice: Dear peer reviewer, please read the methods section. Sincerely, everyone
Carlo Croce, a cancer researcher who has faced numerous research misconduct allegations, recently accused a former lab member of misconduct. Although an institutional probe did not support that allegation, Croce’s efforts have led to a retraction.
In November 2015, Croce and another cancer researcher at Ohio State University (OSU), Ramiro Garzon, contacted PLOS ONE, alleging that the paper’s corresponding author, Stefan Costinean, published data without their knowledge or permission and without “accurately acknowledging their contributions to the research.” Although the PLOS ONE paper mentioned Croce’s and Garzon’s contributions in the acknowledgements section, the two were not included as co-authors. We have obtained a copy of the report describing OSU’s preliminary probe; it did not find evidence of misconduct, but recommended the paper be retracted for using data without permission. Although Costinean disagreed, the journal has since retracted the paper.
Croce has been on the other side of this process: Seven of his papers have been retracted for issues including manipulation and duplication. After a New York Times article, published in March, explored misconduct allegations against Croce, OSU said the university is “instituting an independent external review.” Croce is currently suing the New York Times, alleging that the newspaper defamed him in the story.
What Caught Our Attention: This isn’t a retraction — rather, it’s a puzzling paper that we couldn’t help flagging for readers. From the title, to the affiliation (Das Nursing Home, India University Of God), to the reference list with only 11 entries — eight of which are written by the author himself — this is a paper that got our notice.
Last week, a Swedish government funding agency announced 325 recipients of grants in Natural and Engineering Sciences. We don’t normally write about grant announcements, but we’re flagging this one because one recipient may be familiar to our readers.
It is Peter Eklöv of Uppsala University, a co-author of a now-retracted Science paper about the potential dangers of microplastics to fish.
Eklov will receive 800,000 ($94,784 USD) each year in 2018-2020 and 900,000 ($106,632 USD) in 2021, totalling 3,300,000 ($355,440 USD). The granting agency is the Swedish Research Council, controlled by Sweden’s Ministry of Education and Research.